Issue 25, 2025, Issue in Progress

Photothermal therapeutic effects and biosafety of a carbon nanoparticles–Fe(ii) complex for triple-negative breast cancer

Abstract

Triple-negative breast cancer (TNBC) has become a major challenge in clinical treatment due to its highly aggressive nature and limited therapeutic options. A carbon nanoparticles–Fe(II) complex (CNSI–Fe), as both a ferroptosis inducer and photothermal agent (PTA), could exert anticancer effects through the ferroptosis pathway and photothermal action. Herein, we evaluated the photothermal therapeutic effects of CNSI–Fe in mice bearing the model tumor of TNBC (4T1 tumor). The therapeutic effects of CNSI–Fe were compared without/with near-infrared (NIR) irradiation both in vitro and in vivo. The therapeutic mechanisms and biosafety were also investigated. CNSI–Fe exhibits excellent photothermal conversion efficiency. CNSI–Fe had significant cytotoxicity against TNBC cells, and photothermal therapy (PTT) further enhanced its antitumor effects. The combination of CNSI–Fe and PTT treatments exhibited a more pronounced tumor-suppressive effect and longer survival time comparing to single modality treatment. Mechanistic studies indicated that PTT facilitated the entry of iron ions from CNSI–Fe into cancer cells, generating more hydroxyl radicals and significantly enhancing the ferroptosis. The haematological and serum biological parameters associated with the histopathological observations indicated that the side-effects of CNSI–Fe were low during PTT. Overall, we evidenced the synergistic effect of CNSI–Fe chemotherapy and PTT for TNBC treatment with low toxicity.

Graphical abstract: Photothermal therapeutic effects and biosafety of a carbon nanoparticles–Fe(ii) complex for triple-negative breast cancer

Supplementary files

Article information

Article type
Paper
Submitted
30 Apr 2025
Accepted
04 Jun 2025
First published
10 Jun 2025
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2025,15, 19665-19675

Photothermal therapeutic effects and biosafety of a carbon nanoparticles–Fe(II) complex for triple-negative breast cancer

Y. Huang, K. Tang, G. Zeng, H. Yuan, Q. Xin, Y. Zhao, T. Qu, J. Yang, C. Zeng, X. Wu, Z. Gou, P. Xie, S. Yang and X. Tang, RSC Adv., 2025, 15, 19665 DOI: 10.1039/D5RA03041B

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements